[Clinical study of bromazepam. Thirty cases (author's transl)].

Abstract	The anxiolytic activity of a new benzodiazepine derivative, bomazepam, was investigated in 30 ambulatory patients treated for psychotic or neurotic disorders. The effectivenss and safety of the drug were assessed at the different stages of the study by means of Hamilton's anxiety scale and Guelfi and Pull somatic scale. As all tranquillizers of the benzodiazepine group, bromazepam proved effective against anxiety and associated somatic symptoms. Indoses ranging from one to three 6 mg tablets per day (6-18 mg), the drug was extremely well tolerated, even by elderly patients.
Authors	D Sechter, F Petitjean, G Bitoun
Journal	La Nouvelle presse medicale (Nouv Presse Med) Vol. 11 Issue 22 Pg. 1744-6 (May 13 1982) ISSN: 0301-1518 [Print] France
Vernacular Title	Etude clinique du bromazépam. Trente observations.
PMID	6124949 (Publication Type: English Abstract, Journal Article)
Chemical References	Anti-Anxiety Agents Bromazepam
Topics	Adolescent Adult Aged Anti-Anxiety Agents (therapeutic use) Anxiety Disorders (drug therapy, psychology) Bromazepam (adverse effects, therapeutic use) Drug Evaluation Female Humans Male Middle Aged Psychiatric Status Rating Scales

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!